MAURICE H. WALD, M.S., M.D.
In 1949 the first of these cases of secondary amyloidosis in tuberculosis came under my observation. The date is important, since this general survey of amyloidosis was begun at a time when the new combined chemotherapeutic and surgical attack upon tuberculosis was to improve the prognosis even in far advanced cases.
Because reversal of amyloidosis secondary to tuberculosis has been recorded as a rare event in scattered clinical reports,1, 2, 3 and doubt has been expressed2 that amyloid deposits are ever re-absorbed, the subject seemed worthy of investigation. Likewise, a review of the nature of hepatic impairment in this disease
Learn more about subscription options.
Register Now for a free account.
WALD MH. CLINICAL STUDIES OF SECONDARY AMYLOIDOSIS IN TUBERCULOSIS(CLINICAL STUDIES OF SECONDARY AMYLOIDOSIS IN TUBERCULOSIS*). Ann Intern Med. 1955;43:383–395. doi: 10.7326/0003-4819-43-2-383
Download citation file:
Published: Ann Intern Med. 1955;43(2):383-395.
Infectious Disease, Mycobacterial Infections.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only